[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to the liabilities of that section of the Act but shall be]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to the liabilities of that section of the Act but shall be]
[SCHEDULE 13G (Amendment No. 2) Bitauto Holdings Limited (Name of Issuer) 1 Ordinary Shares, Par Value US$0.00004 Per Share (Title of Class of Securities) 2 091727 107 (CUSIP Number) December 11, 2013 (Date of Event which Requires Filing of this Statement) * 1 2 _______________________________ 1. NAMES OF REPORTING PERSONS 1 Bertelsmann SE & Co. KGaA 2. CHECK THE APPROPRIATE]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to the liabilities of that section of the Act but shall be]
[Guoqing Li 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ x (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 1 130,303,270 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 2 130,303,270 8 SHARED]
[PROSPECTUS SUPPLEMENT (To Prospectus dated August 19, 2013) 5,000,000 Shares Seaspan Corporation 8.25% Series E Cumulative Redeemable Perpetual Preferred Shares (Liquidation Preference $25 Per Share) We are offering 5,000,000 of our 8.25% Series E Cumulative Redeemable Perpetual Preferred Shares, par value $0.01 per share, liquidation preference $25.00 per share (the Series E Preferred Shares). Dividends on the Series E Preferred]
[China Green Agriculture, Inc. Reports the Financial Results for the Second Quarter of Fiscal Year 2014, Provides Guidance of Revenue and Net Income for the Third Quarter of Fiscal Year 2014, and Updates Guidance of Revenue and Net Income for Fiscal Year 2014 XI'AN, China, February 10, 2014 /PRNewswire-Asia-FirstCall/ — · Second Quarter of FY 2014 net sales decreased 2.6%] []
[EXECUTION VERSION AMC ENTERTAINMENT INC. AND U.S. BANK NATIONAL ASSOCIATION AS TRUSTEE 5.875% SENIOR SUBORDINATED NOTES DUE 2022 INDENTURE DATED AS OF FEBRUARY 7, 2014 TABLE OF CONTENTS Page ARTICLE I Definitions and Incorporation by Reference 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 19 Section 1.03. Incorporation by Reference of Trust Indenture Act 19 Section 1.04. Rules of] [EXECUTION VERSION AMC ENTERTAINMENT INC. 5.875% Senior Subordinated Notes due 2022 REGISTRATION RIGHTS AGREEMENT February 7, 2014 Citigroup Global Markets Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated As Representatives of the Initial Purchasers, c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Ladies and Gentlemen: Company Initial Purchasers Representatives Securities Purchase Agreement Initial Placement AMC] [SIXTH SUPPLEMENTAL INDENTURE Supplemental Indenture Company Trustee This Sixth Supplemental Indenture, dated as of February 7, 2014 (this WITNESSETH: Indenture Securities WHEREAS, the Company, the Guarantors and the Trustee have heretofore executed and delivered an Indenture, dated as of June 9, 2009 (as supplemented by (i) the First Supplemental Indenture, dated June 24, 2010, (ii) the Second Supplemental Indenture,] []
[DehaierMedical System Limited Company Presentation February 2014 Company Overview Company Overview Vision Management Team Company Milestone About Us NASDAQ Ticker Symbol DHRM Industry Healthcare Segment Medical Equipment Target Markets Hospitals / Home Healthcare Recent Price (1/22/2014) $5.19 Shares Outstanding 4.67 million Market Value (1/22/2014) $23.97 million P/E (1/22/2014) 8.2 Management Equity 30% Fiscal Year End December 31 At a Glance] []
[FORM 10-Q x For the quarterly period ended December 31, 2013 OR o . For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o o Large accelerated filer x Accelerated filer o Non-accelerated filer] [CERTIFICATION I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Ning Cai, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [SYNUTRA INTERNATIONAL, INC. Certification Liang Zhang Chief Executive Officer] [SYNUTRA INTERNATIONAL, INC. Certification Ning Cai Chief Financial Officer]
